SCHEMBL2942917

SCHEMBL2942917

CC(=O)N(C)C[C@H]1CC[C@H](C(=O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.48
PLAT P00750 1/20 0.48
LMNA P02545 1/20 0.48
TAS2R14 Q9NYV8 9/20 0.40
ANPEP P15144 1/20 0.40
ENPEP Q07075 1/20 0.40
LTA4H P09960 1/20 0.38
KMT2A Q03164 2/20 0.35
ALOX5 P09917 1/20 0.35
NPY5R Q15761 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
CYP2C9 P11712 1/20 0.35
PTGIR P43119 1/20 0.35
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
TSHR P16473 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942919 1.00 PLG (0.48) PLGPLATLMNATAS2R14ANPEP
SCHEMBL12164426 0.88
SCHEMBL8594835 0.82 PLG (0.54) PLGPLATLMNATAS2R14ANPEP
SCHEMBL8594838 0.82 PLG (0.54) PLGPLATLMNATAS2R14ANPEP
SCHEMBL20794142 0.81 ANPEP (0.40) ANPEPENPEPALOX5NPY5RALDH1A1
SCHEMBL2946894 0.80 TP53 (0.38) TAS2R14NPY5RALDH1A1PTGIRTSHR
SCHEMBL2946896 0.80 TP53 (0.38) TAS2R14NPY5RALDH1A1PTGIRTSHR
Hydrochloric Acid SCHEMBL2941904 0.80 PLG (0.52) PLGPLATLMNATAS2R14ANPEP
SCHEMBL13744929 0.80 ALOX5 (0.38) ALOX5NPY5RALDH1A1PTGIR
Hydrochloric Acid SCHEMBL2941906 0.80 PLG (0.52) PLGPLATLMNATAS2R14ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489078-B1 BENZOFURAN DERIVATIVE MITSUBISHI TANABE PHARMA CORP (JP) 2010-01-06 EP disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 US disclosed
US-20050282808-A1 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2005-12-22 US disclosed
EP-1489078-A1 BENZOFURAN DERIVATIVE Tanabe Seiyaku Co., Ltd. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282808-A1 Benzofuran derivative F12, F2, F11 PLG 436/4885PLAT 89/4885LMNA 3104/4885
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 PLG 438/4885PLAT 95/4885LMNA 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.